scholarly journals Efficient RNA-mediated reprogramming of human somatic cells to naïve pluripotency facilitated by tankyrase inhibition

2019 ◽  
Author(s):  
Nicholas Bredenkamp ◽  
Jian Yang ◽  
James Clarke ◽  
Giuliano Giuseppe Stirparo ◽  
Ferdinand von Meyenn ◽  
...  

ABSTRACTIn contrast to conventional human pluripotent stem cells (hPSC) that are related to post-implantation embryo stages, naïve hPSC exhibit features of pre-implantation epiblast. Naïve hPSC are established by resetting conventional hPSC, or are derived from dissociated embryo inner cell masses. Here we investigate conditions for transgene-free reprogramming of human somatic cells to naïve pluripotency. We find that tankyrase inhibition promotes RNA-mediated induction of naïve pluripotency. We demonstrate application to independent human fibroblast cultures and endothelial progenitor cells. We show that induced naïve hPSC can be clonally expanded with a diploid karyotype and undergo somatic lineage differentiation following formative transition. Induced naïve hPSC lines exhibit distinctive surface marker, transcriptome, and methylome properties of naïve epiblast identity. This system for efficient, facile, and reliable induction of transgene free naïve hPSC offers a robust platform, both for delineation of human reprogramming trajectories and for evaluating the attributes of isogenic naïve versus conventional hPSC.




2020 ◽  
Vol 15 (1) ◽  
pp. 274
Author(s):  
Lucas Lange ◽  
Dirk Hoffmann ◽  
Adrian Schwarzer ◽  
Teng-Cheong Ha ◽  
Friederike Philipp ◽  
...  


2020 ◽  
Vol 14 (1) ◽  
pp. 122-137 ◽  
Author(s):  
Lucas Lange ◽  
Dirk Hoffmann ◽  
Adrian Schwarzer ◽  
Teng-Cheong Ha ◽  
Friederike Philipp ◽  
...  


2021 ◽  
Author(s):  
Kezhou Qin ◽  
Jun Yang

AbstractEndothelial progenitor cells (EPCs) and endothelial cells (ECs) have been applied in the clinic to treat pulmonary arterial hypertension (PAH), a disease characterized by disordered pulmonary vasculature. However, the lack of sufficient transplantable cells before the deterioration of disease condition is a current limitation to apply cell therapy in patients. It is necessary to differentiate pluripotent stem cells (PSCs) into EPCs and identify their characteristics. Comparing previously reported methods of human PSCs-derived ECs, we optimized a highly efficient differentiation protocol to obtain cells that match the phenotype of isolated EPCs from healthy donors. The protocol is compatible with chemically defined medium (CDM), it could produce a large number of clinically applicable cells with low cost. Moreover, we also found PSCs-derived EPCs express CD133, have some characteristics of mesenchymal stem cells and are capable of homing to repair blood vessels in zebrafish xenograft assays. In addition, we further revealed that IPAH PSCs-derived EPCs have higher expression of proliferation-related genes and lower expression of immune-related genes than normal EPCs and PSCs-derived EPCs through microarray analysis. In conclusion, we optimized a highly efficient differentiation protocol to obtain PSCs-derived EPCs with the phenotypic and molecular characteristics of EPCs from healthy donors which distinguished them from EPCs from PAH.



2013 ◽  
Vol 10 (2) ◽  
pp. 195-202 ◽  
Author(s):  
Wing Y. Chang ◽  
Jessie R. Lavoie ◽  
Sarah Y. Kwon ◽  
Zhaoyi Chen ◽  
Janet L. Manias ◽  
...  




2015 ◽  
Vol 15 (1) ◽  
pp. 122-129 ◽  
Author(s):  
Xiaoping Bao ◽  
Xiaojun Lian ◽  
Kaitlin K. Dunn ◽  
Mengxuan Shi ◽  
Tianxiao Han ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document